HSA — authorised 29 March 1993
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
HSA authorised Lovenox (Preservative Free) on 29 March 1993
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 29 March 1993.
SANOFI AVENTIS US holds the Singaporean marketing authorisation.